These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32189533)

  • 41. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
    Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Sugarman J; Liu H; Jacovella J;
    J Drugs Dermatol; 2014 Nov; 13(11):1380-6. PubMed ID: 25607706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New developments in the treatment of rosacea - role of once-daily ivermectin cream.
    Cardwell LA; Alinia H; Moradi Tuchayi S; Feldman SR
    Clin Cosmet Investig Dermatol; 2016; 9():71-7. PubMed ID: 27051311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First ex vivo cultivation of human Demodex mites and evaluation of different drugs on mite proliferation.
    Clanner-Engelshofen BM; Ständer LM; Steegmüller T; Kämmerer T; Frommherz LH; Stadler PC; Gürtler A; Reinholz M
    J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2499-2503. PubMed ID: 35881081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ivermectin treatment in rosacea: How novel smartphone technology can support monitoring rosacea-associated signs and symptoms.
    Schaller M; Riel S; Bashur R; Kurup N; Schnidar H; Fehrenbacher B
    Dermatol Ther; 2022 Nov; 35(11):e15869. PubMed ID: 36177738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea?
    Forton FMN
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1229-1253. PubMed ID: 33095403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [PATHOGENETIC FEATURES AND METHODS FOR TREATMENT OF VARIOUS FORMS OF ROSACEA].
    Tsiskarishvili T; Katsitadze A; Tsiskarishvili NV; Tsiskarishvili NI; Chitanava L
    Georgian Med News; 2019 Apr; (289):116-120. PubMed ID: 31215891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demodex positive discoid lupus erythematosus: Is it a separate entity or an overlap syndrome?
    Dursun R; Durmaz K; Oltulu P; Ataseven A
    Dermatol Ther; 2020 May; 33(3):e13394. PubMed ID: 32275797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Granulomatous rosacea in a lung transplant recipient : A possible therapy option in a unique group of patients].
    Ansorge C; Technau-Hafsi K
    Hautarzt; 2020 Feb; 71(2):134-138. PubMed ID: 31560078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Demodex mites in acne rosacea.
    Roihu T; Kariniemi AL
    J Cutan Pathol; 1998 Nov; 25(10):550-2. PubMed ID: 9870674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular Manifestations of Patients With Cutaneous Rosacea With and Without Demodex Infection.
    Kara YA; Çalış F; Gürel İB
    Cutis; 2021 Jul; 108(1):46-50. PubMed ID: 34397359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Demodex and ocular surface disease].
    Ben Hadj Salah W; Baudouin C; Doan S; Angoulvant A; Gottlieb J; Bénichou J; Da Cunha E; Eid L; Labetoulle M; Rousseau A
    J Fr Ophtalmol; 2020 Dec; 43(10):1069-1077. PubMed ID: 33127178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.
    Steinhoff M; Vocanson M; Voegel JJ; Hacini-Rachinel F; Schäfer G
    Adv Ther; 2016 Sep; 33(9):1481-501. PubMed ID: 27432381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The value of reflectance confocal microscopy in detection of Demodex mites].
    Harmelin Y; Le Duff F; Passeron T; Lacour JP; Bahadoran P
    Ann Dermatol Venereol; 2017; 144(6-7):459-461. PubMed ID: 28347561
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical applications of topical ivermectin in dermatology.
    Zargari O; Aghazadeh N; Moeineddin F
    Dermatol Online J; 2016 Sep; 22(9):. PubMed ID: 28329606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and erythema-directed imaging evaluation of papulo-pustular rosacea with topical ivermectin: a 32 weeks duration study.
    Dall'Oglio F; Lacarrubba F; Luca M; Boscaglia S; Micali G
    J Dermatolog Treat; 2019 Nov; 30(7):703-707. PubMed ID: 30663445
    [No Abstract]   [Full Text] [Related]  

  • 56. Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin.
    Allen KJ; Davis CL; Billings SD; Mousdicas N
    Cutis; 2007 Aug; 80(2):149-51. PubMed ID: 17944176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea.
    Lacey N; Russell-Hallinan A; Zouboulis CC; Powell FC
    Br J Dermatol; 2018 Aug; 179(2):420-430. PubMed ID: 29532463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ivermectin: A Review in Rosacea.
    Deeks ED
    Am J Clin Dermatol; 2015 Oct; 16(5):447-52. PubMed ID: 26254001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [THE RATIONALE FOR THE POSSIBLE ROLE OF DEMODEX FOLLICULORUM IN THE PATHOGENESIS OF ROSACEA].
    Tsiskarishvili T; Katsitadze A; Tsiskarishvili N; Chitanava L
    Georgian Med News; 2019 Feb; (287):95-98. PubMed ID: 30958297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.